Study shows use of feces as building material by termites serves as antibiotic
Researchers engineer bacterium to hunt down and kill pathogens
Study finds scorpion venom able to heal bacterial infections in mice
Best of Last Week: Questioning Higgs finding, possible alternative to antibiotics and reversing diabetes in mice
How zinc starves lethal bacteria to stop infection
(Phys.org) —Australian researchers have found that zinc can 'starve' one of the world's most deadly bacteria by preventing its uptake of an essential metal.
Antibacterial silver nanoparticles are a blast
Writing in the International Journal of Nanoparticles, Rani Pattabi and colleagues at Mangalore University, explain how blasting silver nitrate solution with an electron beam can generate nanoparticles that are more effect ...
New technique controls crystalline structure of titanium dioxide
Researchers from North Carolina State University have developed a new technique for controlling the crystalline structure of titanium dioxide at room temperature. The development should make titanium dioxide ...
Nano rescues skin: Shrimp shell nanotech for wound healing and anti-aging face cream
Nanoparticles containing chitosan have been shown to have effective antimicrobial activity against Staphylococcus saprophyticus and Escherichia coli. The materials could be used as a protective wound-healing material to a ...
Roses not only beautiful, but healing
A rose not just romances, it heals.
Scientists unveil 3-D structure of 'molecular machine' that initiates DNA transcription after 3 decades of searching
An team of Rutgers University scientists led by Richard H. Ebright and Eddy Arnold has determined the three-dimensional structure of the transcription initiation complex, the key intermediate in the process by which cells ...
Best of Last Week – speed of light may be wrong, fungus fights resistant bacteria and link between pesticides and autism
Attacking MRSA with metals from antibacterial clays
In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.